|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/12 | |
| C07D 401/14 | |||
| C07D 403/12 | |||
| C07D 405/14 | |||
| A61K 31/517 | |||
| A61K 31/5377 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3050880 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14849754.8 |
| Europos patento paraiškos padavimo data | 2014-09-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-08-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-06-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2014/087633 |
| Data | 2014-09-28 |
| (87) | Numeris | WO 2015/043515 |
| Data | 2015-04-02 |
| (30) | Numeris | Data | Šalis |
| 201310452885 | 2013-09-28 | CN |
| (72) |
XIAO, Dengming, CN
ZHU, Yan, CN
HU, Yuandong, CN
WANG, Huting, CN
LI, Jijun, CN
PENG, Yong, CN
ZHANG, Hui, CN
LUO, Hong, CN
KONG, Fansheng, CN
HAN, Yongxin, CN
|
| (73) |
Lianyungang Runzhong Pharmaceutical Co., Ltd.,
No. 16 Jinqiao Road Dapu Industry Park Lianyungang Economy and Technology Development Zone, Lianyungang, Jiangsu 222069,
CN
Chia Tai Tianqing Pharmaceutical Group Co.,Ltd, No. 369 Yuzhou South Road Haizhou District, Lianyungang, Jiangsu 222062, CN Centaurus BioPharma Co., Ltd., No.16 Building No.3 Minzhuang Road Haidian District, Beijing 100195, CN |
| (54) | QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER |
| QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER |